Rainer Kleemann
- Small Animals top 5%
- Genetics top 10%
- Diabetes and associated disorders 5
-
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 2
- Equine top 10%
- Animal Science and Zoology top 10%
-
- Pancreatic function and diabetes 3
-
- Antimicrobial Peptides and Activities 2
- Microbial infections and disease research 2
-
- Cardiovascular Function and Risk Factors 2
-
- Diet and metabolism studies 2
-
- Cardiovascular Conditions and Treatments 2
- Co-authors
- Hubert KolbStéphan MartinKerstin BellmannFraser W. ScottH. RotheJ RadonsA WenzVolker Burkart
- Partner nations
- GermanyCanadaUnited Kingdom
In The Last Decade
Rainer Kleemann
17 papers receiving 750 citations
Peers
Comparison fields: 5 of 93
- Small Animals 85
- Genetics 275
- Endocrinology, Diabetes and Metabolism 161
- Equine 15
- Animal Science and Zoology 72
Countries citing papers authored by Rainer Kleemann
This map shows the geographic impact of Rainer Kleemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Kleemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Kleemann more than expected).
Fields of papers citing papers by Rainer Kleemann
This network shows the impact of papers produced by Rainer Kleemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Kleemann. The network helps show where Rainer Kleemann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rainer Kleemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 4 | |
| 2 | Clinical efficacy of meloxicam (Metacam) and flunixin (Finadyne) as adjuncts to antibacterial treatment of respiratory disease in fattening cattle. | 2004 | 17 |
| 3 | Investigation on the clinical efficacy and safety of meloxicam (Metacam) in the treatment of non-infectious locomotor disorders in pigs. | 2004 | 26 |
| 4 | 2003 | 66 | |
| 5 | 2002 | 18 | |
| 6 | 2002 | 67 | |
| 7 | 1999 | 4 | |
| 8 | 1998 | 33 | |
| 9 | 1997 | 30 | |
| 10 | 1997 | 17 | |
| 11 | 1997 | 78 | |
| 12 | 1996 | 42 | |
| 13 | 1995 | 134 | |
| 14 | 1994 | 101 | |
| 15 | 1994 | 11 | |
| 16 | Rapid communications Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4 | 1994 | 1 |
| 17 | 1993 | 132 |
About Rainer Kleemann
Rainer Kleemann is a scholar working on Equine, Microbiology and Small Animals, having authored 17 papers that have together received 781 indexed citations. Recurring topics across this work include Diabetes and associated disorders (5 papers), Pancreatic function and diabetes (3 papers), Antimicrobial Peptides and Activities (2 papers), Cardiovascular Function and Risk Factors (2 papers), Diet and metabolism studies (2 papers), Cardiovascular Conditions and Treatments (2 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers) and Microbial infections and disease research (2 papers). The work is most often cited by research in Small Animals (85 citations), Genetics (275 citations) and Endocrinology, Diabetes and Metabolism (161 citations). Rainer Kleemann has collaborated with scholars based in Germany, Canada and United Kingdom. Frequent co-authors include Hubert Kolb, Stéphan Martin, Kerstin Bellmann, Fraser W. Scott, H. Rothe, J Radons, A Wenz, Volker Burkart, Paul Rowsell and Carl Nathan. Their work appears in journals such as Journal of Clinical Investigation, Diabetes and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.